Multidisciplinary Team Meeting Breast Care

Slides:



Advertisements
Similar presentations
Community Hospital Review – The Clinical Model What did we recommend? Dr. David Carson, Director, The Primary Care Foundation.
Advertisements

March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
Trust Cancer Lead Clinician
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
JCUH NICE MSCC Guidelines Compliance audit Ruth Mhlanga Senior Specialist Physiotherapist Oncology and Haematology.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Our Service in 10 Mins Claire Ikwan-McCabe Acute Oncology Nurse Friday, 19th April 2013.
Hospital Operational Standards Jennie Hall, Chief Nurse Dr Ros Given-Wilson, Medical Director Martin Wilson, Director of Delivery and Improvement.
May 2001 Management of Thyroid Cancer Information Projects Team THE MANAGEMENT OF PATIENTS WITH THYROID CANCER Cathy Bennett Information Projects Manager.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
Anne Snow, Lead Cancer Nurse Dr Andrew Woolley – Consultant Physician.
Training for organisations participating in Peer Review of Paediatric Diabetes.
Gynaecological Oncology Patient Pathway Cecile Bergzoll Gynaecological Oncologist Wellington.
Peer Review for Paediatric Diabetes Ruth Bridgeman.
Nurse Led Discharge Mater Misericordiae University Hospital Hilda Dowler, ADON Nursing Quality.
Case for change Burden of disease – each week around 250 diagnoses and 115 deaths in West Yorkshire. Cancer ‘roadmap’ set out in FYFV and Cancer Taskforce.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
WiFi name: WifiLoveMCR Password: internet Join the conversation on Twitter using #DrivingChange
Title of the Change Project
National Oesophago–Gastric Cancer Audit 2015.
SWAG Cancer Alliance Update
The 100,000 Genomes Project and the West of England Genomic Medicine Centre Brief update and overview provided by Catherine Carpenter-Clawson, Programme.
Managing Headache.
Dr James Carlton, Medical Adviser
CRUK working group MDT effectiveness proposal
Managing Headache.
Multi-Disciplinary Team Meeting Reforms
Around 357,000 people in the UK were diagnosed with cancer in 2014.
Achieving World-Class Cancer Outcomes A Strategy for England
Neuro Oncology Therapy Update
Achieving World-Class Cancer Outcomes A Strategy for England
Lung Cancer Pathways: Interim Report
Around 357,000 people in the UK were diagnosed with cancer in 2014.
The BAHNO Head & Neck Cancer Surveillance Audit 2018
Principal recommendations
Inquiry into geographical inequalities in breast cancer
Making MDTs better Steve Falk
Achieving World-Class Cancer Outcomes A Strategy for England
100,000 Genomes Project & Mainstreaming Genomic Medicine
Clinical Audit Summary Guide
‘Improving Outcomes for people with skin tumours, including Melanoma’
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Achieving World-Class Cancer Outcomes A Strategy for England
Somerset, Wiltshire, Avon & Gloucestershire Cancer Alliance
Multi-Disciplinary Team Meeting Reforms
Worcestershire Colorectal Cancer 2ww Pathway
The BAHNO Head & Neck Cancer Surveillance Audit 2018
2018 National Mesothelioma Audit
Multi-Disciplinary Team Meeting Reforms
Regional Melanoma & Complex Skin Cancer Meeting
Regional Oncology Social Work
Our operational plan 2018/19.
Impact of 2019 Sarcoma Service specification for Bristol
Multi-Disciplinary Team Meeting Reforms
Jaspal Phull Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Service.
Multi-Disciplinary Team Meeting Reforms
Patient centred care & Concept of Multidisciplinary team (MDT) Mr A A Ayantunde, MD; FRCS; FWACS, FRCS (Gen & Colorectal Surgery) Consultant Laparoscopic.
Citizen-Led Multi-agency Safeguarding Adults Policy and Procedures
Breast Multidisciplinary Team Meetings
Living With & Beyond Cancer: SWAG Breast SSG Update
28 Day Faster Diagnosis Standard
A good MDT MDT working is considered the gold standard for cancer patient management bringing continuity of care and reducing variation in access.
MULTIDISCIPLINARY (MDT) APPROACH TO CLINICAL CARE MODEL FOR EFFECTIVE AND BEST EVIDENCE PATIENT CARE DR EZEKIEL ALAWALE MBBS, FWACS, FRCS(I), JCPTGP, GP.
Stroke Protocols Ensure Efficient Patient Intake, Diagnosis, Treatment
Airedale NHS Foundation Trust
A good MDT MDT working is considered the gold standard for cancer patient management bringing continuity of care and reducing variation in access.
Calderdale and Huddersfield NHS Foundation Trust
NHS Long Term Plan: Rapid Diagnostic Centres (RDC) The SWAG Approach
Leeds Teaching Hospitals Trust
Mid-Yorkshire Hospitals
Presentation transcript:

Multidisciplinary Team Meeting Breast Care (Improvement Project Work ) West Yorkshire and Harrogate Cancer Alliance) striving for excellence Striivng for Excellence

Introduction This project is following on from commissioned work by CRUK to improve the effectiveness of the MDTM. 5.51 (Achieving World Class Cancer Outcomes: A strategy for England 2015 - 2020) The High Quality Services (HQS) Project Group asked the Trusts to consider piloting a study from these initial discussion/ findings. Our team in Harrogate agreed to participate with the aim of reviewing and considering possible recommendations to implement change Aim to improve the effectiveness of MDT meetings in cancer. (CRUK). Commissioned work identified key themes:-not enough time, attendance not optimal, Right information often not used to inform discussion.In line with this the numbers of cases for discussion are increasing. This creates a longer MDT, which may have an impact on the length of time spent on each case, and the quality of discussion could be questioned. striving for excellence Striivng for Excellence

MDT Pilot Question Recommendation 1   Question Recommendation 1 Should pre-meetings be held to ensure only the correct patients are discussed at length in MDTs The Pre-Meeting MDT does not fit all MDT’s and therefore Trusts  need to identify which MDTs would benefit from holding a pre-meeting 2 Could some patients be streamlined or reviewed outside of the meeting, providing that this was undertaken to a strict protocol? There should be development of  specific MDT protocols for patients who could be streamlined outside of the full MDT meeting 3 Could the pre-MDT act to make recommendations for patients deemed straightforward and to ensure diagnostic information is ready by the full MDT discussion There should be development of  protocolised pathways for straightforward patients 4 Patients are regularly deferred for another MDT - how could this be improved? There should be an interim forum between MDTs to make decisions when results are available. MDTs should consider developing WhatsApp type groups/cohorts 5 How could patients with metastatic disease or more complex patients (co-morbidities, cardiorespiratory etc.) be better managed through the MDT? MDTs should  collate and standardise the required information needed to enable optimal MDT discussion making for complex and metastatic patients striving for excellence

The table below shows which Trusts and Tumour Sites have agreed to participate. Pilot Airedale Gynaecology Recommendation 3 Bradford Lung Considering recommendations 2, 3 and 5 Calderdale & Huddersfield Are planning to pilot the Red/green principles at a small team meeting on Monday/Wednesday/Friday to progress patients through their pathway Colorectal Recommendation 4 Harrogate Breast Recommendation 2 Mid Yorks Skin Upper GI Recommendation 1 Leeds York Are planning to develop a ‘mini-MDT’ and a daily board round of patients on the cancer pathway striving for excellence

MDT MDT working is deemed as the gold standard for patient management, bringing continuity of care and improving outcomes for patients. (2015 Cancer Strategy) MDT meetings (MDTM) provide a forum for health care professionals to discuss and make recommendations on their management of care. The core members of these teams are professionals such as consultants, medical and clinical oncologists, radiologists, pathologists, clinical nurse specialists and MDT co-ordinators. Each of these disciplines contributes his/her skills and knowledge to the discussions of the patients (Hall and Weaver, 2001). striving for excellence Striivng for Excellence

HDFT Referrals striving for excellence Striivng for Excellence

Projected new diagnoses UK Current striving for excellence Striivng for Excellence

More Patients, More Complex, More Therapies. MDT More Patients, More Complex, More Therapies. MDT need to adapt to new pressures and discussions should focus more on difficult cases. Processes should be put in place to enable swifter decisions on patients going through standard treatment pathways. Achieving World Class Cancer Outcomes: A strategy for England striving for excellence

Project Aim Review literature both national and local projects Retrospective analysis of MDT proformas over a 3 month period of patients discussed Look for traits/ patterns which may identify areas to possibly change practice Create a policy/ protocol (if appropriate), to consider change – present to the team Prospective analysis - for a month - present to the team Implement change striving for excellence

Ideal Results Streamline the number of cases/ relevance Allow more time for each case Maintain a full complement of team members during the meeting     striving for excellence

Analysis of data * 3 months data will not capture possible patients discussed out of this time scale ( snap shot). From the data it is evident that approximately quarter (24%) of the discussions were benign cases. 22% New Cancers – encompasses the triple assessment process/ discussion. 22% with imaging review - is separate imaging e.g. Staging CT ,MRI. 26% Histology (all malignant) – Post op WLE / MASTECTOMY/ CAVITY SHAVE 1% Complex refers to anything out of the ‘ routine’ breast pathway - e.g. Pathology requiring further work up and discussion at other MDTs 5% other – query re breast screening f/up 24% Benign striving for excellence Striivng for Excellence

Project Focus 86% of benign cases were reassured and discharged following discussion at MDT striving for excellence

Considerations 1. Should the benign cases be discussed within the MDT meeting with a full compliance of core member attendance?   ABC Best Practice Diagnostic Guidelines state: “The diagnostic MDM must include pathologist, radiologist or consultant radiographer in breast imaging, surgeon or breast clinician and breast care nurse.” 2. Is it an efficient use of clinical time to have the full quoracy for MDT in attendance throughout all discussions, including benign cases?  From previous discussion it has been suggested to increase the length of time of the MDT to an hour and a half. If it is deemed appropriate to increase the MDT time by 50%, what impact will this have on the core members; this will need: -Revision of job plans to allow time for attendance -Consideration of impact on patient clinical time (In terms of oncology clinic, this could possibly equate to 1.5 follow up appointments or almost 1 new patient per week.) -Cost implications -This will require full monitoring of MDT quoracy striving for excellence Striivng for Excellence

Considerations 3. Could the obviously benign cases be grouped together for discussion at the start of the meeting incorporating the appropriate attendance? Protocol/guidance – B3 or above to remain on main MDT, B2 or below to be discussed in benign section of MDT. 4. Would a pre-MDT triage be helpful in streamlining the MDT discussions more efficiently? E.G the obvious benign concordant cases not to be discussed at MDT Watch this space – 5. Should the team consider the MDT coordinator’s input/workload in collecting information for the comprehensive proformas – could the proformas be simplified (in accordance with guidance/data analysis)? Anecdotal evidence indicates that it takes an estimated 4-6 hours per week to compile proformas. New patient proformas often take longer to complete estimated as approximately 20 mins per proforma. When the majority (86% of benign cases) of these are being reassured and discharged we need to consider whether there is a more efficient way of documenting such cases. striving for excellence

Agreed plan going forward Start MDT at 12:30 pm, list benign cases at the beginning for discussion. Radiologist, pathologist, one breast surgeon (if on leave) needed for discussion of benign cases. Oncology presence not needed till 1 pm, till full MDT starts. Time taken to discuss each benign to be recorded. MDT to review MDT proforma to ensure reduction in time MDT coordinator spent on completing details. Review in one month Presentation of project and outcomes to be presented 28th March 1 – 4 pm Horizon, Leeds striving for excellence